Pfizer’s (PFE) Buy Rating Reaffirmed at Guggenheim
Pfizer (NYSE:PFE – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Guggenheim in a research note issued on Wednesday,Benzinga reports. Several other brokerages have also issued reports on PFE. Citigroup dropped their target price on Pfizer from $30.00 to $29.00 and set a “neutral” rating for the company in […]
Pfizer (NYSE:PFE – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Guggenheim in a research note issued on Wednesday,Benzinga reports. Several other brokerages have also issued reports on PFE. Citigroup dropped their target price on Pfizer from $30.00 to $29.00 and set a “neutral” rating for the company in […]
